These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31306409)

  • 1. Developing the first national database and map of lymphatic filariasis clinical cases in Bangladesh: Another step closer to the elimination goals.
    Karim MJ; Haq R; Mableson HE; Sultan Mahmood ASM; Rahman M; Chowdhury SM; Rahman AKMF; Hafiz I; Betts H; Mackenzie C; Taylor MJ; Kelly-Hope LA
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007542. PubMed ID: 31306409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical case estimates of lymphatic filariasis in an endemic district of Bangladesh after a decade of mass drug administration.
    Hafiz I; Graves P; Haq R; Flora MS; Kelly-Hope LA
    Trans R Soc Trop Med Hyg; 2015 Nov; 109(11):700-9. PubMed ID: 26464232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of lymphatic filariasis as a public health problem in Malawi.
    Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated morbidity mapping of lymphatic filariasis and podoconiosis cases in 20 co-endemic districts of Ethiopia.
    Kebede B; Martindale S; Mengistu B; Kebede B; Mengiste A; H/Kiros F; Tamiru A; Davey G; Kelly-Hope LA; Mackenzie CD
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006491. PubMed ID: 29965963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a community-led SMS reporting tool for the rapid assessment of lymphatic filariasis morbidity burden: case studies from Malawi and Ghana.
    Stanton MC; Mkwanda SZ; Debrah AY; Batsa L; Biritwum NK; Hoerauf A; Cliffe M; Best A; Molineux A; Kelly-Hope LA
    BMC Infect Dis; 2015 May; 15():214. PubMed ID: 25981497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system.
    Mwingira U; Chikawe M; Mandara WL; Mableson HE; Uisso C; Mremi I; Malishee A; Malecela M; Mackenzie CD; Kelly-Hope LA; Stanton MC
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005748. PubMed ID: 28708825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
    Mehta PK; Maharjan M
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significant scale up and success of Transmission Assessment Surveys 'TAS' for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020.
    Shamsuzzaman AK; Haq R; Karim MJ; Azad MB; Mahmood AS; Khair A; Rahman MM; Hafiz I; Ramaiah KD; Mackenzie CD; Mableson HE; Kelly-Hope LA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005340. PubMed ID: 28141812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-economic and environmental factors associated with high lymphatic filariasis morbidity prevalence distribution in Bangladesh.
    Williams T; Karim MJ; Uddin S; Jahan S; Asm SM; Forbes SP; Hooper A; Taylor MJ; Kelly-Hope LA
    PLoS Negl Trop Dis; 2023 Jul; 17(7):e0011457. PubMed ID: 37432968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Programme to Eliminate Lymphatic Filariasis from Ethiopia.
    Mengistu B; Deribe K; Kebede F; Martindale S; Hassan M; Sime H; Mackenzie C; Mulugeta A; Tamiru M; Sileshi M; Hailu A; Gebre T; Fentaye A; Kebede B
    Ethiop Med J; 2017; 55(Suppl 1):45-54. PubMed ID: 28878429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphedema in three previously Wuchereria bancrofti-endemic health districts in Mali after cessation of mass drug administration.
    Dolo H; Coulibaly YI; Konipo FN; Coulibaly SY; Doumbia SS; Sangare MB; Soumaoro L; Coulibaly ME; Diallo AA; Diarra Y; Sangare M; Doumbia S; Colebunders R; Nutman TB
    BMC Infect Dis; 2020 Jan; 20(1):48. PubMed ID: 31941448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the National Programme to Eliminate Lymphatic Filariasis on filariasis morbidity in Sri Lanka: Comparison of current status with retrospective data following the elimination of lymphatic filariasis as a public health problem.
    Gunaratna IE; Chandrasena NTGA; Vallipuranathan M; Premaratna R; Ediriweera D; de Silva NR
    PLoS Negl Trop Dis; 2024 Aug; 18(8):e0012343. PubMed ID: 39141877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
    Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
    Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic filariasis morbidity mapping: a comprehensive examination of lymphoedema burden in Chikwawa district, Malawi.
    Smith EL; Mkwanda SZ; Martindale S; Kelly-Hope LA; Stanton MC
    Trans R Soc Trop Med Hyg; 2014 Dec; 108(12):751-8. PubMed ID: 25282001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities.
    Biritwum NK; Frempong KK; Verver S; Odoom S; Alomatu B; Asiedu O; Kontoroupis P; Yeboah A; Hervie ET; Marfo B; Boakye DA; de Vlas SJ; Gyapong JO; Stolk WA
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007115. PubMed ID: 31398203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity hotspot surveillance: A novel approach to detect lymphatic filariasis transmission in non-endemic areas of the Tillabéry region of Niger.
    Badia-Rius X; Adamou S; Taylor MJ; Kelly-Hope LA
    Parasite Epidemiol Control; 2023 May; 21():e00300. PubMed ID: 37138586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wuchereria bancrofti infection in rural tropical guinea savannah communities: Rapid epidemiological assessment using immunochromatographic card test and prevalence of hydrocoele.
    Ivoke N; Ezeabikwa BO; Ivoke ON; Ekeh FN; Ezenwaji NE; Odo GE; Onoja US; Eyo JE
    Trop Biomed; 2015 Jun; 32(2):365-75. PubMed ID: 26691265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana.
    Biritwum NK; Yikpotey P; Marfo BK; Odoom S; Mensah EO; Asiedu O; Alomatu B; Hervie ET; Yeboah A; Ade S; Hinderaker SG; Reid A; Takarinda KC; Koudou B; Koroma JB
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):690-695. PubMed ID: 28938053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity management and surveillance of lymphatic filariasis disease and acute dermatolymphangioadenitis attacks using a mobile phone-based tool by community health volunteers in Ghana.
    Debrah LB; Mohammed A; Osei-Mensah J; Mubarik Y; Agbenyega O; Ayisi-Boateng NK; Pfarr K; Kuehlwein JM; Klarmann-Schulz U; Hoerauf A; Debrah AY
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008839. PubMed ID: 33180780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.
    Graves PM; Makita L; Susapu M; Brady MA; Melrose W; Capuano C; Zhang Z; Dapeng L; Ozaki M; Reeve D; Ichimori K; Kazadi WM; Michna F; Bockarie MJ; Kelly-Hope LA
    Parasit Vectors; 2013 Jan; 6():7. PubMed ID: 23311302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.